We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Rapid, Automated Test Detects Gonorrhea and Determines Antibiotic Susceptibility

By LabMedica International staff writers
Posted on 24 May 2021
Print article
Image: Dr. Tza-Huei Wang displays the PROMPT test cartridge for rapid diagnosis of gonorrhea infection (Photo courtesy of Johns Hopkins University)
Image: Dr. Tza-Huei Wang displays the PROMPT test cartridge for rapid diagnosis of gonorrhea infection (Photo courtesy of Johns Hopkins University)
An inexpensive, portable diagnostic test that gives results in only 15 minutes is expected to revolutionize detection of sexually transmitted diseases such as gonorrhea.

Effective treatment of sexually transmitted diseases (STIs) - such as gonorrhea with more than 87 million cases worldwide each year - is limited by diagnostic methods that cannot deliver results rapidly while the patient is still in the clinic. Currently gonorrhea is diagnosed by classical culture methods or with more advanced, but expensive and time consuming, nucleic acid-based techniques such as PCR.

To address the need for fast and affordable diagnostic tests for STIs, investigators at Johns Hopkins University (Baltimore, MD, USA) developed a portable, rapid, on-cartridge magnetofluidic purification and testing (PROMPT) polymerase chain reaction (PCR) test.

The PROMPT device uses an automated procedure to analyze swab samples of urethral or penile fluid. First, the swab sample is mixed with a solution of magnetic particles in a tube, and a drop of the mixture is loaded into a cartridge, which snaps into the device. The device transfers the magnetized particles to reagents in the cartridge, which carries out 40 PCR cycles before displaying the results on the screen of a cellphone. Probes in the cartridge enable the device to both identify the presence of Neisseria gonorrhoeae, the pathogen causing gonorrhea, as well as genotyping the pathogen for the DNA signature linked to resistance to the antimicrobial drug ciprofloxacin. Results are received in less than 15 minutes.

The PROMPT device was used to analyze penile swab samples from sexual health clinics in Baltimore, MD, USA (n = 66) and Kampala, Uganda (n = 151) with an overall sensitivity and specificity of 97.7% and 97.6%, respectively, for N. gonorrhoeae detection and 100% concordance with culture results for ciprofloxacin resistance.

"Our portable, inexpensive testing platform has the potential to change the game when it comes to diagnosing and enabling rapid treatment of sexually transmitted infections," said senior author Dr. Tza-Huei Wang, professor of mechanical engineering at Johns Hopkins University. "It ensures that patients are diagnosed on the spot, and treatment can begin immediately, improving clinical outcomes. This will be especially valuable in low-resource settings, where well-equipped laboratories are not always available to every patient."

The PROMPT device for rapid diagnosis of gonorrhea was described in the May 12, 2021, online edition of the journal Science Translational Medicine.

Related Links:
Johns Hopkins University

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The cobas Malaria test is the first FDA-approved molecular test to screen U.S. blood donors for malaria (Photo courtesy of Roche)

First FDA-Approved Molecular Test to Screen Blood Donors for Malaria Could Improve Patient Safety

Malaria, a serious illness that often leads to death, is spread by a specific mosquito species that infect humans with a parasite. Other transmission modes include blood transfusions, organ transplants,... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The medical office procedure detects the key biomarker in Parkinson’s and related neurodegenerative diseases (Photo courtesy of BIDMC)

Simple Skin Biopsy Test Detects Parkinson’s and Related Neurodegenerative Diseases

Parkinson's disease and a group of related neurodegenerative disorders known as synucleinopathies impact millions globally. These conditions, including Parkinson’s disease (PD), dementia with Lewy bodies... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.